Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective StudyNaoto Okada, Keisuke Ishizawa, Yoshihiro Matsudate et al.|Clinical Therapeutics|2018Cited by 99